History of Ataxias and Paraplegias with an Annotation on the First Description of Striatonigral Degeneration.
Berciano J, Gazulla J, Infante J.
Cerebellum. 2022 Aug;21(4):531-544. doi: 10.1007/s12311-021-01328-6. Epub 2021 Nov 3.
[Striatonigral degeneration].
Mochizuki A, Shimizu T.
Nihon Rinsho. 1997 Jan;55(1):123-6.
Striatonigral degeneration.
Kan AE.
Pathology. 1978 Jan;10(1):45-52. doi: 10.3109/00313027809063478.
Striatonigral degeneration. A case report and a review of the literature.
van Leeuwen RB, Perquin WV.
Clin Neurol Neurosurg. 1988;90(2):121-4. doi: 10.1016/s0303-8467(88)80030-1.
Neuroprotective effect of L-DOPA-induced interleukin-13 on striatonigral degeneration in cerebral ischemia.
Jeon E, Seo MS, Lkhagva-Yondon E, Lim YR, Kim SW, Kang YJ, Lee JS, Lee BD, Wi R, Won SY, Chung YC, Park ES, Kim E, Jin BK, Jeon MS.
Cell Death Dis. 2024 Nov 22;15(11):854. doi: 10.1038/s41419-024-07252-x.
Novel VAC14 variants identified in two Chinese siblings with childhood-onset striatonigral degeneration.
Liao S, Chen T, Dai Y, Wang Y, Wu F, Zhong M.
Mol Genet Genomic Med. 2020 Feb;8(2):e1101. doi: 10.1002/mgg3.1101. Epub 2019 Dec 26.
[Striatonigral degeneration (SND)].
Kita K.
Ryoikibetsu Shokogun Shirizu. 1999;(27 Pt 2):254-6.
Ageing and Parkinson's disease: substantia nigra regional selectivity.
Fearnley JM, Lees AJ.
Brain. 1991 Oct;114 ( Pt 5):2283-301. doi: 10.1093/brain/114.5.2283.
[Striatonigral degeneration (SND)].
Koyama K, Kuroiwa Y.
Ryoikibetsu Shokogun Shirizu. 1999;(27 Pt 2):49-51.
Striatonigral degeneration.
Koeppen AH, Barron KD, Cox JF.
Acta Neuropathol. 1971;19(1):10-9. doi: 10.1007/BF00690949.
